Global Veterinary Biologicals Market Growth 2025-2031
Description
The global Veterinary Biologicals market size is predicted to grow from US$ million in 2025 to US$ million in 2031; it is expected to grow at a CAGR of %from 2025 to 2031.
Pet medical care is the second largest segment in pet industry. In the UK, annual spending on veterinary and other pet services has risen from £2.6bn in 2015 to £4bn in 2021, a 54% increase in just six years. According to Vetnosis, the value of the global animal health industry will increase by 12% to $38.3 billion in 2021. White Paper on China"s Pet Healthy Consumption of JD shows that in 2023, there are 13.09 million pets entering middle age and old age. And pet aging is expected to be seen in the next few years. Changes in the age structure of pets will further bring about the development of the pet medical industry. According to the data of the 2022 China Pet Medical Industry White Paper, from the perspective of market size, the scale of China"s pet medical market is about ¥67.5 billion, accounting for about 22.5% of the entire pet industry. From the perspective of hospital operation time, pet hospitals within 5 years accounted for about 73%. About 11% of the pet hospitals have been in operation for more than 10 years. From the perspective of hospital turnover, nearly 40% of the hospitals have increased their annual turnover year-on-year, and the growth rate is mainly within 576%.
LP Information, Inc. (LPI) ' newest research report, the “Veterinary Biologicals Industry Forecast” looks at past sales and reviews total world Veterinary Biologicals sales in 2024, providing a comprehensive analysis by region and market sector of projected Veterinary Biologicals sales for 2025 through 2031. With Veterinary Biologicals sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Veterinary Biologicals industry.
This Insight Report provides a comprehensive analysis of the global Veterinary Biologicals landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Veterinary Biologicals portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Veterinary Biologicals market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Veterinary Biologicals and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Veterinary Biologicals.
This report presents a comprehensive overview, market shares, and growth opportunities of Veterinary Biologicals market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
Preventive Veterinary Biologicals
Therapeutic Veterinary Biologicals
Segmentation by Application:
Poultry
Livestock
Pet
Wild Animals
Fishes
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
Boehringer Ingelheim
Zoetis
Virbac, Inc.
Heska Corporation
Kyoto Biken
FATRO
Elanco
Merck Animal Health
China Animal Husbandry Industry Co.,Ltd.
Tianjin Ringpu Bio-technology Co.,Ltd.
Pulike Biological Engineering,Inc.
Jinyu Bio-Technology Co.,Ltd.
Tecon Biology Co.,Ltd.
Shanghai Hile Bio-Technology Co.,Ltd.
Jinhe Biotechnology Co.,Ltd.
Shandong Lukang Pharmaceutical Co.,Ltd.
Wuhan Keqian Biology Co., Ltd.
Key Questions Addressed in this Report
What is the 10-year outlook for the global Veterinary Biologicals market?
What factors are driving Veterinary Biologicals market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Veterinary Biologicals market opportunities vary by end market size?
How does Veterinary Biologicals break out by Type, by Application?
Please note: The report will take approximately 2 business days to prepare and deliver.
Pet medical care is the second largest segment in pet industry. In the UK, annual spending on veterinary and other pet services has risen from £2.6bn in 2015 to £4bn in 2021, a 54% increase in just six years. According to Vetnosis, the value of the global animal health industry will increase by 12% to $38.3 billion in 2021. White Paper on China"s Pet Healthy Consumption of JD shows that in 2023, there are 13.09 million pets entering middle age and old age. And pet aging is expected to be seen in the next few years. Changes in the age structure of pets will further bring about the development of the pet medical industry. According to the data of the 2022 China Pet Medical Industry White Paper, from the perspective of market size, the scale of China"s pet medical market is about ¥67.5 billion, accounting for about 22.5% of the entire pet industry. From the perspective of hospital operation time, pet hospitals within 5 years accounted for about 73%. About 11% of the pet hospitals have been in operation for more than 10 years. From the perspective of hospital turnover, nearly 40% of the hospitals have increased their annual turnover year-on-year, and the growth rate is mainly within 576%.
LP Information, Inc. (LPI) ' newest research report, the “Veterinary Biologicals Industry Forecast” looks at past sales and reviews total world Veterinary Biologicals sales in 2024, providing a comprehensive analysis by region and market sector of projected Veterinary Biologicals sales for 2025 through 2031. With Veterinary Biologicals sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Veterinary Biologicals industry.
This Insight Report provides a comprehensive analysis of the global Veterinary Biologicals landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Veterinary Biologicals portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Veterinary Biologicals market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Veterinary Biologicals and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Veterinary Biologicals.
This report presents a comprehensive overview, market shares, and growth opportunities of Veterinary Biologicals market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
Preventive Veterinary Biologicals
Therapeutic Veterinary Biologicals
Segmentation by Application:
Poultry
Livestock
Pet
Wild Animals
Fishes
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
Boehringer Ingelheim
Zoetis
Virbac, Inc.
Heska Corporation
Kyoto Biken
FATRO
Elanco
Merck Animal Health
China Animal Husbandry Industry Co.,Ltd.
Tianjin Ringpu Bio-technology Co.,Ltd.
Pulike Biological Engineering,Inc.
Jinyu Bio-Technology Co.,Ltd.
Tecon Biology Co.,Ltd.
Shanghai Hile Bio-Technology Co.,Ltd.
Jinhe Biotechnology Co.,Ltd.
Shandong Lukang Pharmaceutical Co.,Ltd.
Wuhan Keqian Biology Co., Ltd.
Key Questions Addressed in this Report
What is the 10-year outlook for the global Veterinary Biologicals market?
What factors are driving Veterinary Biologicals market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Veterinary Biologicals market opportunities vary by end market size?
How does Veterinary Biologicals break out by Type, by Application?
Please note: The report will take approximately 2 business days to prepare and deliver.
Table of Contents
140 Pages
- 1 Scope of the Report
- 2 Executive Summary
- 3 Global by Company
- 4 World Historic Review for Veterinary Biologicals by Geographic Region
- 5 Americas
- 6 APAC
- 7 Europe
- 8 Middle East & Africa
- 9 Market Drivers, Challenges and Trends
- 10 Manufacturing Cost Structure Analysis
- 11 Marketing, Distributors and Customer
- 12 World Forecast Review for Veterinary Biologicals by Geographic Region
- 13 Key Players Analysis
- 14 Research Findings and Conclusion
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
